← Open Payments lookup

MATTHEW REESE: Open Payments

NPI 1558731919 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$630 in 27 payments from 10 companies in 2025. Trend: 2023 $714 · 2024 $1,164 · 2025 $630

Food & beverage: $630
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc5$127
Otsuka America Pharmaceutical, Inc.3$119
ABBVIE INC.5$94
Neurocrine BioSciences, Inc.2$59
Teva Pharmaceuticals USA, Inc.3$56
Alkermes, Inc.2$47
Vanda Pharmaceuticals Inc.2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
E.R. Squibb & Sons, L.L.C.2$28
Axsome Therapeutics, Inc.1$24

Products named: INVEGA, VRAYLAR, ABILIFY MAINTENA, INGREZZA, UZEDY, ARISTADA, FANAPT, REXULTI.

Industry payments across LA — which companies pay providers there.